The newly tradeable ETFs from Rize ETF are focusing on thematic market trends with growth stories: medical cannabis and cyber security. Rize ETF developed both ETFs in cooperation with the index provider Foxberry and the respective thematic experts New Frontier Data and Tematica Research. These products offer investors additional opportunities to diversify their portfolios and dip into the ever-thriving segment of equity-themed ETFs available at SIX. Liquidity for the 2 ETFs is provided by Société Générale.
“We are delighted to welcome Rize ETF to the Swiss Stock Exchange. The listing of two innovative ETFs further broadens our platform and enables investors to benefit from exposure to thematic market trends. With the newly launched products of Rize ETF, the offering of the ETF segment increases to almost 1’600 products” says Alain Picard, Head Trading Sales & Management, Securities & Exchanges, SIX. “The ETF segment at SIX registered over 900’000 transactions in the first six months of 2020 – representing a year-over-year growth of 75%.”
Rize ETF specializes exclusively in thematic ETFs and offer purpose-built products, to balance long-term returns with exposure to companies that have a positive impact on the world. The underlying investment strategies of the ETFs center on growth stories and are developed in collaboration with dedicated research houses and index providers. The product offering of Rize ETF is aimed at both, institutional and individual investors. Rize ETF provides services along the entire value chain of the ETF: From the definition of the investment strategy and product structuring to portfolio management and distribution. https://rizeetf.com/
Product Name | Trading Currency | ISIN | Market Maker |
Rize Cybersecurity and Data Privacy UCITS ETF – USD Accumulating ETF | CHF | IE00BJXRZJ40 | Société Générale |
Rize Medical Cannabis and Life Sciences UCITS ETF – USD Accumulating ETF | CHF | IE00BJXRZ273 | Société Générale |
Further information on the ETF-Segment is published online:
Please do not hesitate to contact Julian Chan.